Antibodies, Assay Kits, Biology Cells, Clia Kits, Culture Cells, Devices, DNA, Equipments, Exosomes, Gels, Isotypes, Particles, PCR, Recombinant Proteins, Ria Kits, RNA, Test Kits

Agaricus Blazei Polipeptide provides a protection effect on aging mice caused by D-galactose through KAPE1 / NRF2 / is and P53 / PRIM32 signaling pathways

Agaricus Blazei Polipeptide provides a protection effect on aging mice caused by D-galactose through KAPE1 / NRF2 / is and P53 / PRIM32 signaling pathways
Posted by Anna

This experiment mainly optimizes Agaricus Blazei Polipeptide (ABP) extraction technology and evaluates the protection effect on aging mice. In this study, a new single component, M 3 KD, isolated and purified from Agaricus Blazei. The aging mouse model was established using D-galactose. After the ABP administration, the contents of total antioxidant capacity (T-AOC), malondialdehyde (MDA), catalase (cat), and reactive oxygen species changed significantly. Through immunofluorescence staining, observed that ABP can reduce brain tissue changes. The expression of the generation of genes was analyzed by RNA-SEQ.

A total of 295 genes expressed differently filtered in the ABP Gen Group.rt-QPCR verify the important gene and show that the level of MRNA HSPH1, Trim32, HNRNPA1, and Grik5 expression increased significantly, and people from APOE, ATP1A3, STXBP1, and MAPK8IP1 decreased significantly. West Blotting shows that the level of expression of KAPE1 and P53 protein is significantly lower, while the level of protein expression of NRF2, HO-1, HSPH1, and TRIM32 is significantly higher in the ABP group.

ABP plays an anti-aging role in a rat aging model. Specific work mechanisms may be related to the expression regulations of the KAPE1 / NRF2 / P53 signaling path and related factors. Practical application: This research can contribute to the development of ABP as functional food or food supplements for anti-aging in the future.

Carboxyl-terminal polypeptide fragment from MUC16 Combing Stathmin1 promotes migration and bile cancer cell invasion

CA-125, encoded by Gen MUC16, is responsible for various types of tumor metastasis. However, related mechanisms are still unclear. We have set new ways to reveal gallbladder cancer metastasis related to the serum level CA-125 through C-terminal polypeptides from Gen16 production. MUC16 C-terminal polypeptides significantly promote bile cancer cell migration and in vitro invasion. The mass spectrum indicates that the interaction of MUC16 terminal C fragment with the C-STATHmin1 terminal domain inhibits STATHMIN1 phosphorylation to promote combinations with tubulins.

STATHMIN1 Knockdown Inhibits migration and invasion of bile cancer cells in vitro and metastasis in vivo lungs caused by polypeptides Terminal C-terminal MUC16. The level of high expression of MUC16C is consistent with STATHMIN1 is also confirmed in the gallbladder cancer tissue. Our study revealed the mechanism that underlies the gallbladder cancer metastasis related to the level of CA-125, which is useful for CA-125 in the diagnosis and therapy of gallbladder cancer.

Localization of vasoactive polypeptide receptor 1 (VPAC1) in neuroendocrine hypothalamic neuroendocrine neurons; Potential role in circadian prolactin secretion

Prolactin (PRL) is a versatile hormone and presents various physiological functions other than lactation. The release of the PRL from lactotrof in the hypophysis owned in mice is proven to be released with a circadian pattern depending on the physiological state of the animal. The release of the Circadian PRL seems to be a complex involving tonic inhibition by dopamine (DA) neurons in lactotrof and one or even several release factors. Because of the pattern of release of circadian PRL, neurons in the suprachiasmatic nucleus (SCN), “brain clock,” and especially neurons that express neuropeptide vasoactive polypeptide intestine (VIP), have been advised to be involved in the circadian regulation.

Agaricus Blazei Polipeptide provides a protection effect on aging mice caused by D-galactose through KAPE1 / NRF2 / is and P53 / PRIM32 signaling pathways

In this study, we use immunohistochemical fluorescence, in hybridization histochemistry situ, confocal microscope, three-dimensional reconstruction, and very specific antibodies to visualize the occurrence of VIP 1 and 2 receptors (VPAC1 and VPAC2) in the stained mouse hypothalamic section in combination with VIP , Oxytocin (OXT), Arginine Vasopresin (AVP), and DA (Tyrosine hydroxylase, th). We show that VIP fiber is likely to come from the ventral part of the SCN project to OXT neurons in the magnocelluler part of nucleus paraventricular (PVN).

In PVN, VIP fibers found in the application close to Oxt Neurons exclusively express VPAC1 receptors. Next, we show that Oxt neurons or AVP neurons do not express VPAC2 receptors. The expression of VPAC receptors is also found in blood vessels but not in neurons that express AVP or th. These findings indicate that VIP signaling from the SCN does not directly target neurons involved in the PLL secretion. Furthermore, the findings support the idea that the VIP from neurons in the SCN can regulate the release of circadian oxt in pituitary neurons or posterior modulation as the release factor involved in the temperature regulation of lactotrof.

Pancreas polypeptides but not other members of the Neuropeptide Y family show a moderate relationship with anxiety felt in a fat man

Neuropeptide Y (NPY), Peptide Tyrosine Tyrosine (PYY), and Pancreatic Polypeptide (PP) is an important mediator in two-way communication along the intestinal axis. Most famous for their role in taste rules and their food intake is considered to play an important role in the development of obesity. In addition, evidence of installation shows regulatory functions in anxiety, mood and stress resistance with gender potential differences. In this study, we examined the association of NPY, PYY, and PP plasma levels with anxiety, depression and stress felt in obesity patients.

We analyzed 144 inpatients (90 women, 54 men, BMI: 49.4 kg / m2) in naturalistic care settings for obesity and somatic and mental comorbidity. Fasting blood samples were taken, and the patient completed the psychometric self-assessment questionnaire (GAD-7, PHQ-9, PSQ-20) in the first week after entering and before exiting. The plasma concentration of peptides was measured by Elisa. Women showed higher anxiety (GAD-7: 8.13 ± 5.67 vs 5.93 ± 5.42, p = 0.04) and stress scores (PSQ-20: 52.62 ± 23.5 vs 41.23 ± 0.01 ) than men. In the longitudinal analysis of women with increasing clinically relevant anxiety (≥ 5 points at GAD-7, P <0.001) also showed a significant increase in depression (PHQ-9: 38%, p = 0.002) and PSQ-20 score (23) %, p = 0.005) while male patients who enhanced anxiety only increased in the tension of the PSQ-20 subscale (34%, p = 0.02).

In the man we observed the positive correlation of PP with anxiety scores (GAD-7: R = 0.41, p = 0.007) and with age (r = 0.49, p = 0.001) when entered while NPY correlated negatively with age (r = -0.38), p = 0.01). Instead, there was no significant association (P> 0.05) on the subject of women in cross-sectional and in longitudinal analysis. In conclusion, women who suffer from terrible obesity show greater psychological comorbidity and considerable interaction between them.

PTCHD2 Antibody

24792 100ul
EUR 479

PTCHD2 Antibody

24792-100ul 100ul
EUR 468

PTCHD2 Antibody

24797 100ul
EUR 479

PTCHD2 Antibody

24797-100ul 100ul
EUR 468

PTCHD2 Antibody

25404 100ul
EUR 479

PTCHD2 Antibody

25404-100ul 100ul
EUR 468

PTCHD2 Antibody

4915-002mg 0.02 mg
EUR 206.18
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism.

PTCHD2 Antibody

4915-01mg 0.1 mg
EUR 523.7
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism.

PTCHD2 Antibody

4925-002mg 0.02 mg
EUR 206.18
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism.

PTCHD2 Antibody

4925-01mg 0.1 mg
EUR 523.7
Description: PTCHD2 Antibody: PTCHD2, also known as DISP3, is the third of three known homologs of the D. melanogaster protein Dispatched. It is a multi-transmembrane protein containing two PTCH/DISP domains and is thought to be involved in the release of lipid-anchored secreted proteins. Like DISP1 and DISP2, DISP3 has been implicated in signaling pathways during embryogenesis, tissue regeneration, and carcinogenesis. It is highly expressed in Purkinje cells, hippocampal neurons, and retinal ganglion cells. Recently, it has been shown that PTCHD2 localizes within the endoplasmic reticulum and colocalizes with cholesterol, and given that its expression is regulated by thyroid hormone (T3), it has been suggested that DISP3 may be a link between thyroid hormone and cholesterol metabolism.

PTCHD2 (untagged)-Human patched domain containing 2 (PTCHD2)

SC316598 10 µg Ask for price

PTCHD2 (GFP-tagged) - Human patched domain containing 2 (PTCHD2)

RG211355 10 µg Ask for price

Ptchd2 (untagged) - Mouse patched domain containing 2 (Ptchd2), (10ug)

MC224316 10 µg Ask for price

Ptchd2 (GFP-tagged) - Mouse patched domain containing 2 (Ptchd2), (10ug)

MG223294 10 µg Ask for price

Ptchd2 (Myc-DDK-tagged) - Mouse patched domain containing 2 (Ptchd2)

MR223294 10 µg Ask for price

PTCHD2 (Myc-DDK-tagged)-Human patched domain containing 2 (PTCHD2)

RC211355 10 µg Ask for price

Polyclonal PTCHD2 Antibody

AMR09590G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications:

Polyclonal PTCHD2 Antibody

AMR09591G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications:

Polyclonal PTCHD2 Antibody

AMR09592G 0.1 mg
EUR 790.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 . This antibody is tested and proven to work in the following applications:

Mast Cell-Degranulating Peptide (MCD Peptide) / Peptide 401

004-04 100 μg
EUR 140.4

AAP94899-100UG - Ptchd3 Blocking peptide (N terminal region)

AAP94899-100UG 100ug
EUR 99

Human PTCHD2 shRNA Plasmid

20-abx961520
  • Ask for price
  • Ask for price
  • 150 µg
  • 300 µg

Lenti ORF clone of Ptchd2 (mGFP-tagged) - Mouse patched domain containing 2 (Ptchd2)

MR223294L4 10 µg Ask for price

Rabbit Polyclonal PTCHD2 Antibody

TA319981 100 µg Ask for price

Rabbit Polyclonal PTCHD2 Antibody

TA319982 100 µg Ask for price

Rabbit Polyclonal PTCHD2 Antibody

TA319983 100 µg Ask for price

PTCHD2 ORF Vector (Human) (pORF)

ORF028512 1.0 ug DNA Ask for price

Ptchd2 ORF Vector (Mouse) (pORF)

ORF055152 1.0 ug DNA
EUR 1886.4

Lenti ORF clone of Ptchd2 (Myc-DDK-tagged) - Mouse patched domain containing 2 (Ptchd2)

MR223294L3 10 µg Ask for price

Peptide T

057-01 5 mg
EUR 140.4

Human PTCHD2 knockout cell line

ABC-KH12357 1 vial Ask for price
Description: Human PTCHD2 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology.

FGL Peptide

073-36 100 μg
EUR 214.92

APK peptide

076-81 200 μg
EUR 199.8

NEF peptide

076-83 500 μg
EUR 140.4

SHA peptide

076-84 500 μg
EUR 177.12

YSY peptide

076-86 100 μg
EUR 230.04

Human PTCHD2 knockdown cell line

ABC-KD12357 1 vial Ask for price
Description: Human PTCHD2 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest.

PSTAIR Peptide

070-61 500 μg
EUR 129.6

PGMtide Peptide

040-69 100 μg
EUR 316.44

Peptide E / 3200-Dalton Adrenal Enkephalin-Containing Peptide (Bovine)

024-57 200 μg
EUR 86.4

Adjuvant Peptide

070-05 500 μg
EUR 36.72

proSex peptide (20-55)

040-30 100 μg
EUR 355.32

proSex peptide (28-55)

040-31 100 μg
EUR 282.96

proSex peptide (40-55)

040-32 100 μg
EUR 214.92

Peptide-epsilon

058-22 500 μg
EUR 114.48

Delicious Peptide

070-21 5 mg
EUR 160.92

Peptide F-9

038-06 200 μg
EUR 58.32

Sturgeon Peptide (137-158)

021-94 100 μg
EUR 177.12

NGR Peptide 1

025-74 200 μg
EUR 184.68

Peptide Lv (Rat)

008-73 100 μg
EUR 469.8

Bombinin-Like Peptide 1 amide / prepro-Bombinin-Like Peptide (44-70) amide / prepro-Bombinin-Like Peptide (107-133) amide

007-60 100 μg
EUR 214.92

Bid BH3 peptide

025-87 1 mg
EUR 170.64

AF-16 Peptide

033-44 200 μg
EUR 214.92

Anorexigenic Peptide

070-10 5 mg
EUR 86.4

GnRH Associated Peptide (GAP) (1-13) / GnRH Precursor Peptide (14-26) (Human)

029-03 500 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-24) / GnRH Precursor Peptide (14-37) (Human)

029-04 100 μg
EUR 114.48

GnRH Associated Peptide (GAP) (1-53) / GnRH Precursor Peptide (14-66) (Human)

029-05 20 μg
EUR 267.84

GnRH Associated Peptide (GAP) (25-53) / GnRH Precursor Peptide (38-66) (Human)

029-06 100 μg
EUR 114.48

Peptide Lv (Human)

008-71 100 μg
EUR 405

Peptide Lv (Mouse)

008-72 100 μg
EUR 469.8

Peptide B (Bovine)

024-56 200 μg
EUR 81

Peptide F (Bovine)

024-58 200 μg
EUR 114.48

ExE peptide M3mP6

064-33 200 μg
EUR 244.08

Polyclonal PTCHD2 Antibody (N-Terminus)

AMR09593G 0.05mg
EUR 580.8
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human PTCHD2 (N-Terminus). This antibody is tested and proven to work in the following applications:

GnRH Associated Peptide (GAP) (1-13) / Gn-RH Precursor Peptide (14-26) (Rat)

029-08 200 μg
EUR 64.8

Lenti ORF particles, Ptchd2 (GFP-tagged) - Mouse patched domain containing 2 (Ptchd2), 200ul, >10^7 TU/mL

MR223294L4V 200 µl Ask for price

Lenti ORF particles, PTCHD2 (mGFP-tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL

RC211355L2V 200 µl Ask for price

Lenti ORF particles, PTCHD2 (mGFP-tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL

RC211355L4V 200 µl Ask for price

PLP Peptide (103-116) (Bovine)

070-14 5 mg
EUR 140.4

FMRF-Like Peptide

047-32 1 mg
EUR 27

Joining Peptide (Rat)

047-91 200 μg
EUR 160.92

Peptide T (4-8)

057-04 500 μg
EUR 64.8

Peptide T (5-8)

057-05 500 μg
EUR 64.8

Growth Hormone-Releasing Peptide-Related Peptide-1 (fGRP-RP-1) (Frog)

048-80 500 μg
EUR 177.12

Growth Hormone-Releasing Peptide-Related Peptide-2 (fGRP-RP-2) (Frog)

048-81 200 μg
EUR 214.92

Growth Hormone-Releasing Peptide-Related Peptide-3 (fGRP-RP-3) (Frog)

048-82 200 μg
EUR 214.92

Opioid Peptide Library

L-002 58 peptides
EUR 2691.36

Vasonatrin Peptide (VNP)

005-47 200 μg
EUR 214.92

[D-Ala1]-Peptide T

057-02 5 mg
EUR 282.96

Heparin Binding Peptide

025-47 500 μg
EUR 102.6

Gastrin Related Peptide

027-09 5 mg
EUR 73.44

PGMtide Control Peptide

040-70 100 μg
EUR 316.44

Growth Blocking Peptide

046-92 100 μg
EUR 255.96

Neuron Specific Peptide

047-55 200 μg
EUR 140.4

Obesity Peptide Library

L-003 160 peptides
EUR 7267.32

Lenti ORF particles, PTCHD2 (Myc-DDK tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL

RC211355L1V 200 µl Ask for price

Lenti ORF particles, PTCHD2 (Myc-DDK tagged) - Human patched domain containing 2 (PTCHD2), 200ul, >10^7 TU/mL

RC211355L3V 200 µl Ask for price

Peptide YY (PYY) (Human)

059-01 200 μg
EUR 119.88

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine)

064-01 200 μg
EUR 108

Lenti ORF particles, Ptchd2 (Myc-DDK-tagged) - Mouse patched domain containing 2 (Ptchd2), 200ul, >10^7 TU/mL

MR223294L3V 200 µl Ask for price

proSex peptide (28-55) - EIA Kit

EK-040-31 96 wells
EUR 603.72

Peptide F 1 (Lobster)

047-62 500 μg
EUR 73.44

Eledoisin Related Peptide

046-04 5 mg
EUR 58.32

Morphine Tolerance Peptide

050-13 1 mg
EUR 102.6

Phosphate Acceptor Peptide

058-24 500 μg
EUR 73.44

PTCHD2 3'UTR GFP Stable Cell Line

TU069132 1.0 ml
EUR 1672.8

Ptchd2 3'UTR GFP Stable Cell Line

TU167223 1.0 ml Ask for price

FGL Peptide - Cy3 Labeled

FC3-073-36 1 nmol
EUR 672.84

FGL Peptide - Cy5 Labeled

FC5-073-36 1 nmol
EUR 756

FGL Peptide - FAM Labeled

FG-073-36A 1 nmol
EUR 405

Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia brasiliana)

047-39 200 μg
EUR 444.96

Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia brasiliana)

047-40 500 μg
EUR 214.92

Peptide I / pro-Histine-Rich Basic Peptide (HRBP) (1-26) (Aplysia californica)

047-42 200 μg
EUR 444.96

Peptide II / pro-Histine-Rich Basic Peptide (HRBP) (29-40) (Aplysia californica)

047-43 500 μg
EUR 214.92

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human)

064-07 200 μg
EUR 114.48

Pedal Peptide (Pep) (Aplysia)

047-61 500 μg
EUR 177.12

Insulin B (22-25) Peptide

035-08 5 mg
EUR 86.4

ExE peptide M3mP6 mutant

064-35 200ug
EUR 234.36

ExE peptide M3mP6 mutant

064-37 200ug
EUR 234.36

FGL Peptide - FITC Labeled

FG-073-36B 1 nmol
EUR 405

AF-16 Peptide - Antibody

H-033-44 100 μl
EUR 336.96

Schizophrenia Related Peptide

047-79 5 mg
EUR 44.28

Ptchd2 sgRNA CRISPR Lentivector set (Mouse)

K3185201 3 x 1.0 ug
EUR 406.8

PTCHD2 sgRNA CRISPR Lentivector set (Human)

K1748901 3 x 1.0 ug
EUR 406.8

Cell Penetrating ARF Peptide (26-44)

068-56 500 μg
EUR 640.44

Eosinophilotactic Peptide (AGSE)

070-28 5 mg
EUR 27

Eosinophilotactic Peptide (VGSE)

070-29 5 mg
EUR 27

FGL Peptide - Biotin Labeled

B-073-36 20 μg
EUR 405

Peptide F (Bovine) - Antibody

H-024-58 50 μl
EUR 238.68

Brain Peptide (Bees) Library

L-007 51 peptides
EUR 6456.24

Peptide R / CXCR4 Antagonist

030-25 200 μg
EUR 203.04

PGMtide Peptide - Cy3 Labeled

FC3-040-69 1 nmol
EUR 925.56

PGMtide Peptide - FAM Labeled

FG-040-69A 5 nmol
EUR 537.84

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - RIA Kit

RK-064-01 125 tubes
EUR 932.04

[D-Arg14, D-Arg15]-MGF Peptide amide / C-terminal peptide of IGF-1 Ec amide

033-34 100 μg
EUR 177.12

Gastrointestinal Peptide Library

L-006 200 peptides
EUR 7267.32

[D-Ala1]-Peptide T amide

057-03 500 μg
EUR 140.4

Peptide F (Bovine) - RIA Kit

RK-024-58 125 tubes
EUR 932.04

Catch-Relaxing Peptide (CARP)

047-20 1 mg
EUR 199.8

Calmodulin Binding Peptide 1

070-17 20 μg
EUR 214.92

FGL Peptide - Rhodamine Labeled

FR-073-36 1 nmol
EUR 537.84

Peptide-Depleted Plasma (Rat)

MB-099-02 2 ml
EUR 119.88

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - Antibody

H-064-07 50 μl
EUR 238.68

Urokinase-Derived Peptide A6

025-12 500 μg
EUR 129.6

PGMtide Peptide - Biotin Labeled

B-040-69 20 μg
EUR 537.84

Anti-Inflammatory Peptide 1

004-01 200 μg
EUR 27

Anti-Inflammatory Peptide 2

004-02 200 μg
EUR 27

Anti-Inflammatory Peptide 3

004-03 200 μg
EUR 27

Peptide 34 / GPR-54 Agonist

048-94 200 μg
EUR 114.48

FGL Peptide - I-125 Labeled

T-073-36 10 μCi
EUR 1145.88

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - RIA Kit

RK-064-07 125 tubes
EUR 932.04

Glycogenolysis-Inhibiting Peptide

023-63 500 μg
EUR 177.12

Peptide-Depleted Plasma (Human)

MB-099-01 2 ml
EUR 119.88

F3 Peptide / HMGN2 Fragment 3

004-12 100 μg
EUR 214.92

Peptide YY (PYY) (3-36) (Human)

059-02 200 μg
EUR 102.6

PTCHD2 Protein Vector (Mouse) (pPM-C-HA)

PV220608 500 ng
EUR 2766

PTCHD2 Protein Vector (Human) (pPM-C-HA)

PV114048 500 ng Ask for price

Fibronectin CS1 Peptide (EILDVPST)

025-20 500 μg
EUR 86.4

Myosin Kinase Inhibiting Peptide

058-20 500 μg
EUR 50.76

Antimicrobial Trp-rich peptide

004-05 100 μg
EUR 140.4

Peptide YY (PYY) (Human) - Antibody

H-059-01 100 μl
EUR 469.8

OAPB01435-100UG - PTCHD2 Antibody - C-terminal

OAPB01435-100UG 100ug
EUR 389

OAPB01436-100UG - PTCHD2 Antibody - N-terminal

OAPB01436-100UG 100ug
EUR 389

OAPB01521-100UG - PTCHD2 Antibody - N-terminal

OAPB01521-100UG 100ug
EUR 389

Peptide A / p60v-src (137-157)

058-21 500 μg
EUR 135

Peptide Histidine Methionine 27 (PHM-27) / Peptide Histidine Isoleucine (PHI) (Human) - FAM Labeled

FG-064-07A 1 nmol
EUR 336.96

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - I-125 Labeled

T-064-01 10 μCi
EUR 1145.88

PTCHD2 Protein Vector (Mouse) (pPB-C-His)

PV220606 500 ng
EUR 2766

PTCHD2 Protein Vector (Mouse) (pPB-N-His)

PV220607 500 ng
EUR 2766

PTCHD2 Protein Vector (Mouse) (pPM-C-His)

PV220609 500 ng
EUR 2766

PTCHD2 Protein Vector (Human) (pPB-C-His)

PV114046 500 ng Ask for price

PTCHD2 Protein Vector (Human) (pPB-N-His)

PV114047 500 ng Ask for price

PTCHD2 Protein Vector (Human) (pPM-C-His)

PV114049 500 ng Ask for price

Ptchd2 3'UTR Luciferase Stable Cell Line

TU117223 1.0 ml Ask for price

PTCHD2 3'UTR Luciferase Stable Cell Line

TU019132 1.0 ml
EUR 1672.8

PGMtide Peptide - Rhodamine Labeled

FR-040-69 5 nmol
EUR 604.8

Anti-Angiogenic Peptide Library

L-008A 88 peptides
EUR 6067.44

C28 optimized peptide 6 (Human)

073-82 100 μg
EUR 235.44

Peptide YY (PYY) (Human) - EIA Kit

EK-059-01 96 wells
EUR 617.76

Peptide YY (PYY) (Human) - RIA Kit

RK-059-01 125 tubes
EUR 814.32

Cancer-Targeting Peptide Library

L-015 289 peptides
EUR 7253.28

pro-Opionmelanocortin / J Peptide

022-22 200 μg
EUR 177.12

Galanin-Like Peptide (GALP) (Rat)

026-52 100 μg
EUR 282.96

PACAP-Related Peptide (PRP) (Rat)

052-11 200 μg
EUR 86.4

Peptide Histidine Isoleucine 27 (PHI-27) / Porcine Intestinal Peptide (Porcine) - Purified IgG Antibody

G-064-01 400 μg
EUR 438.48

Pri Peptide from sORF pri RNA

069-77 200 μg
EUR 160.92

Kemptide / Phosphate Acceptor Peptide

058-16 500 μg
EUR 36.72

Even though we only observed the PP association with anxiety and age with NPY and PP in men, suggesting the possibility of the effect of sex hormones on the NPY system. However, an increase in anxiety scores does not lead to significant changes in NPY.

Related Post

Leave A Comment